Africa-Press – Cape verde. Emprofac clarified, this Friday, that the shortage of insulin on the market is due to difficulties faced by manufacturers. However, he says that there are other slow-acting insulins on the market and that he has already placed several orders with other suppliers, expecting to supply the market later this month.
“Several international manufacturers, such as Sanofi and Novo Nordisk, producers of insulin for the world market, are facing difficulties in the production and supply of this drug, a situation that affects the Cape Verdean market”, clarified the company, in a statement.
In this context, he says that other insulins, of slow action, are on the market and guarantees that “efforts are being made to supply the national market still in April.
best possible solution
“Emprofac has already placed a number of orders with various suppliers to replenish stocks as soon as possible”, says the same source, adding that it is in conjunction with health entities to find the best way to resolve the situation.
He also emphasizes that the country depends exclusively on international suppliers for the purchase of insulin, and that a new order should arrive in the next few days and will be distributed.
For More News And Analysis About Cape verde Follow Africa-Press
